On
15th October 2018 Tim Sandle delivered the key note address to the PDA
Microbiology Europe conference. Tim Sandle has written an article which takes
the form of an edited transcript of the presentation.
Whilst
there is a continuing need for monitoring of the environment and conducting
standardized laboratory tests, pharmaceutical microbiology has moved on to
embrace:
- Microbiological audits;
- Rapid microbiological methods;
- Conducting risk assessments, both proactive in terms of minimizing contamination and reactive, in terms of addressing microbial data deviations;
- Ensuring that processes meet ‘quality by design’ principles;
- And getting the microbiologist away from the bench and into the plant.
These
themes are captured in the auricle, for which the reference is:
For details, please contact Tim Sandle
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology
No comments:
Post a comment
Pharmaceutical Microbiology Resources